tirzepatide week 4 weight loss percentage reduction over time in tirzepatide‐treated participants by early weight response: Post hoc analysis in SURMOUNT‐1 Adults with obesity using tirzepatide

You inject once weekly, and your dose increases are adjustments to the strength of each injection, not to the frequency

Self-compassion matters because small slips are common and reversible

Unlike older treatments that focus on a single pathway, tirzepatide triggers both GLP-1 and GIP receptors, thereby reducing appetite, enhancing insulin sensitivity, and prolonging satiety

The practical result is dramatic

If your pharmacy started you on a lower dose with a 10 mg/mL vial, they may switch you to 20 mg/mL or higher once you reach the 10 mg or 15 mg dose level

The needle should be 31-gauge and 5/16-inch (8 mm) on a U-100 insulin syringe (included with every RxPepsDirect order)